Mustang Bio, Inc. (MBIO) vs Paranovus Entertainment Technology Ltd. (PAVS)
A side-by-side comparison of Mustang Bio, Inc. and Paranovus Entertainment Technology Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 11:48 AM EDT
PAVS
Paranovus Entertainment Technology Ltd.
$3.77HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — MBIO vs PAVS
growth of $100 · dividends reinvested · last 7yMBIO -100.0% (-70.1%/yr)PAVS -100.0% (-88.0%/yr)MBIO compounded faster over this window
Log scale — wide-divergence pair
MBIO PAVS
MBIO vs PAVS: by the numbers
- •MBIO is the larger company ($3M vs $3M market cap).
- •Both run net losses; MBIO's is the smaller (0.00% vs -87.20% net margin).
Metrics side by side
Valuation
| Metric | MBIO | PAVS |
|---|---|---|
| P/B ratio | 0.46 | 0.10 |
Profitability
| Metric | MBIO | PAVS |
|---|---|---|
| Gross margin | 0.00% | 16.54% |
| Operating margin | 0.00% | -23.11% |
| Net margin | 0.00% | -87.20% |
| ROE | -40.20% | -40.75% |
| ROIC | -45.77% | -9.72% |
Growth (annualized)
| Metric | MBIO | PAVS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -27.22% |
| Total return CAGR (5Y) | -80.80% | -92.96% |
Frequently asked
- How have MBIO and PAVS total returns compared?
- Over the past 5 years, MBIO delivered -80.80% and PAVS delivered -92.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.